Sign in

CIK 0001665988 · Accelerated filer<br>Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
810980861
Phone
(919) 474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. 8-K Event Executive or director change
  4. 8-K Event Regulation FD disclosure
  5. 4 Open-market sale SVP & Chief Science Officer sold 433 shares at $11.99 ($5,192)
  6. 4 Option exercise SVP & Chief Science Officer acquired 1,470 shares (option exercise)
  7. 4 Option exercise Director acquired 9,000 shares (option exercise)
  8. 4 Option exercise Director acquired 9,000 shares (option exercise)
  9. 4 Open-market sale SVP & General Counsel sold 1,294 shares at $11.99 ($15,513)
  10. 4 Open-market sale SVP & CFO sold 1,294 shares at $11.99 ($15,518)
  11. 4 Open-market sale Chief Commercial Officer sold 534 shares at $11.99 ($6,401)
  12. 4 Option exercise Director acquired 9,000 shares (option exercise)
  13. 4 Option exercise Director acquired 9,000 shares (option exercise)
  14. 4 Option exercise Director acquired 13,500 shares (option exercise)
  15. 4 Option exercise Director acquired 9,000 shares (option exercise)
  16. 4 Shares withheld for taxes SVP & CHIEF SCIENCE OFFICER gave up 73,915 shares (to pay taxes)
  17. 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 24,205 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP & General Counsel gave up 6,599 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP & CFO gave up 19,674 shares (to pay taxes)
  20. 4 Option exercise Director acquired 38,288 shares (option exercise)

Page 17 of 24 · 463 filings